187 related articles for article (PubMed ID: 32385660)
21. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
Josse RG; Majumdar SR; Zheng Y; Adler A; Bethel MA; Buse JB; Green JB; Kaufman KD; Rodbard HW; Tankova T; Westerhout CM; Peterson ED; Holman RR; Armstrong PW;
Diabetes Obes Metab; 2017 Jan; 19(1):78-86. PubMed ID: 27607571
[TBL] [Abstract][Full Text] [Related]
22. Glycemic control and 10-year odds of all-cause fractures in elderly veterans with type 2 diabetes.
Baltrusaitis SL; Grabarczyk T
Diabetes Res Clin Pract; 2019 May; 151():46-55. PubMed ID: 30904745
[TBL] [Abstract][Full Text] [Related]
23. Glycemic control and fracture risk in elderly patients with diabetes.
Conway BN; Long DM; Figaro MK; May ME
Diabetes Res Clin Pract; 2016 May; 115():47-53. PubMed ID: 27242122
[TBL] [Abstract][Full Text] [Related]
24. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
[TBL] [Abstract][Full Text] [Related]
25. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
[TBL] [Abstract][Full Text] [Related]
26. Mean HbA
Forbes A; Murrells T; Mulnier H; Sinclair AJ
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
[TBL] [Abstract][Full Text] [Related]
27. Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes.
Shen Y; Zhou J; Shi L; Nauman E; Katzmarzyk PT; Price-Haywood EG; Horswell R; Bazzano AN; Nigam S; Hu G
Diabetes Obes Metab; 2021 Jan; 23(1):125-135. PubMed ID: 32965068
[TBL] [Abstract][Full Text] [Related]
28. Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes.
Lee J; Han K; Park SH; Kim MK; Lim DJ; Yoon KH; Kang MI; Lee SH
Metabolism; 2022 Apr; 129():155135. PubMed ID: 35032546
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
[TBL] [Abstract][Full Text] [Related]
30. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
31. Sociodemographic factors associated with HbA1c variability in type 2 diabetes: a prospective exploratory cohort study.
Mellergård E; Johnsson P; Eek F
BMC Endocr Disord; 2020 Jul; 20(1):102. PubMed ID: 32641021
[TBL] [Abstract][Full Text] [Related]
32. Association of hip fractures with cardiometabolic-renal risk factors in Southern Chinese patients with type 2 diabetes - the Hong Kong Diabetes Register.
Yun-Ning Cheung E; Pik-Shan Kong A; Siu-Him Lau E; Yee-Kwan Chow E; On-Yan Luk A; Ching-Wan Ma R; Ping Lam T; Yuk-Wai Lee W; Chun-Yiu Cheng J; Ebeling PR; Chung-Ngor Chan J
J Diabetes Investig; 2021 Sep; 12(9):1739-1748. PubMed ID: 33605046
[TBL] [Abstract][Full Text] [Related]
33. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
[TBL] [Abstract][Full Text] [Related]
34. Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning.
Lee S; Zhou J; Wong WT; Liu T; Wu WKK; Wong ICK; Zhang Q; Tse G
BMC Endocr Disord; 2021 May; 21(1):94. PubMed ID: 33947391
[TBL] [Abstract][Full Text] [Related]
35. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
[TBL] [Abstract][Full Text] [Related]
36. Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.
Balintescu A; Lind M; Franko MA; Oldner A; Cronhjort M; Svensson AM; Eliasson B; Mårtensson J
Diabetes Care; 2022 Jan; 45(1):127-133. PubMed ID: 34716212
[TBL] [Abstract][Full Text] [Related]
37. Visit-to-visit blood pressure variability and hip fracture risk in older persons.
Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Chiang JH; Lin CC
Osteoporos Int; 2019 Apr; 30(4):763-770. PubMed ID: 30789999
[TBL] [Abstract][Full Text] [Related]
38. Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes.
Moran C; Lacy ME; Whitmer RA; Tsai AL; Quesenberry CP; Karter AJ; Adams AS; Gilsanz P
JAMA Neurol; 2023 Jun; 80(6):597-604. PubMed ID: 37067815
[TBL] [Abstract][Full Text] [Related]
39. Visit-to-visit HbA1c variability, dementia, and hippocampal atrophy among adults without diabetes.
Li C; Guo J; Zhao Y; Sun K; Abdelrahman Z; Cao X; Zhang J; Zheng Z; Yuan C; Huang H; Chen Y; Liu Z; Chen Z
Exp Gerontol; 2023 Jul; 178():112225. PubMed ID: 37263368
[TBL] [Abstract][Full Text] [Related]
40. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
